BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Erlotinib
1
Clinical efficacy and safety of erlotinib combined with chemotherapy in the treatment of advanced pancreatic cancer: A meta-analysis
3/22/2024 11:13:53 AM | Browse: 395 | Download: 1119
2
Erlotinib combination with a mitochondria-targeted ubiquinone effectively suppresses pancreatic cancer cell survival
2/21/2024 9:11:33 AM | Browse: 443 | Download: 1839
3
Therapy-related myeloid leukemia during erlotinib treatment in a non-small cell lung cancer patient: A case report
8/24/2021 2:07:00 AM | Browse: 835 | Download: 2356
4
Sustained complete response to erlotinib in squamous cell carcinoma of the head and neck: A case report
3/6/2019 8:51:28 AM | Browse: 1118 | Download: 2188
5
Chemotherapy and target therapy for hepatocellular carcinoma: New advances and challenges
4/19/2015 5:46:00 PM | Browse: 1627 | Download: 2342
6
Erlotinib usage after prior treatment with gefitinib in advanced non-small cell lung cancer: A clinical perspective and review of published literature
12/11/2014 2:06:00 PM | Browse: 1253 | Download: 1823
7
First-line erlotinib and fixed dose-rate gemcitabine for advanced pancreatic cancer
9/15/2014 8:54:00 PM | Browse: 1522 | Download: 1586
8
FDG-PET for predicting efficacy of EGFR-tyrosine kinase inhibitors in lung cancer
9/15/2014 4:56:00 PM | Browse: 1388 | Download: 1688
9
Targeting receptor tyrosine kinases in gastric cancer
8/28/2014 5:50:00 PM | Browse: 1500 | Download: 1828
10
Distinct antifibrogenic effects of erlotinib, sunitinib and sorafenib on rat pancreatic stellate cells
8/26/2014 1:51:00 PM | Browse: 1273 | Download: 1437
11
Translational research in pancreatic ductal adenocarcinoma: current evidence and future concepts
8/20/2014 6:38:00 PM | Browse: 1714 | Download: 1739
Write to the Help Desk
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.